Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul DO

Pediatric Pulmonology Clovis, CA Medical Doctor

NPI 1942326269 CMS profile 178616

726 N Medical Center Dr E Ste 209, Clovis, CA 93611

Open in the dashboard

General payments

$3,737

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul DO of Clovis, CA is reported in the CMS Open Payments database as having received $3,737 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $951 23
2024 General $652 25
2023 General $808 24
2022 General $465 23
2021 General $300 15
2020 General $147 8
2019 General $415 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul DO
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Paul DO were reported at $951. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Paul DO Pediatric Pulmonology median Middle half National median
2019 $415 $151 $59–$495 $163
2020 $147 $107 $34–$339 $114
2021 $300 $125 $40–$511 $132
2022 $465 $133 $49–$428 $149
2023 $808 $138 $44–$494 $160
2024 $652 $132 $46–$398 $164
2025 $951 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $905 46 payments
  2. AstraZeneca Pharmaceuticals LP $691 10 payments
  3. Digestive Care, Inc. $418 7 payments
  4. Mylan Specialty L.P. $248 6 payments
  5. Baxter Healthcare $237 12 payments
  6. Amgen Inc. $222 6 payments
  7. Vertex Pharmaceuticals Incorporated $208 9 payments
  8. Philips Electronics North America Corporation $156 8 payments
  9. Sobi, Inc $128 7 payments
  10. Biogen, Inc. $125 1 payment
  11. Other $399 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,639 127 payments
  2. Education $98 2 payments
Products named General payments · program years 2019–2025
  1. CREON $768 43 payments
  2. TEZSPIRE Respiratory $449 7 payments
  3. Pertzye Gastroenterology $418 7 payments
  4. Pertzye Gastroenterology $418 7 payments
  5. Pertzye Gastroenterology $418 7 payments
  6. Pertzye Gastroenterology $418 7 payments
  7. TOBI Podhaler $248 6 payments
  8. TEZSPIRE Inflammation $188 5 payments
  9. Hillrom - Vest System Model 105 Home Care $164 8 payments
  10. FASENRA $155 2 payments
  11. Other $1,162 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record